BlueStar Genomic Health Care Index

The BlueStar Genomic Health Care Index (BDNANTR) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Index Parameters

Market Capitalisation values are updated daily.

Launch Date: 22 May 2020
Calculator: Standard & Poor's
Dissemination: Realtime
Dissemination Period: 01:00 - 23:00 (CET)
Type: Sector
Currency: USD
Current Components: 81
Base Date: 31 Dec 2015
Base Value: 100
Full Market Cap: 631.01 bn USD
Free-Float Market Cap: 390.69 bn USD
Next Review: 16 Dec 2021

Identifiers

PriceTotal Return NetTotal Return Gross
ISIN: - DE000A3CLKA4 -
Sedol: - BLNPNQ5 -
WKN: - A3CLKA -
Bloomberg: - BDNANTR -
Reuters: - .BDNANTR -
Telekurs: - 57061641 -
FIGI: - BBG00TYNPQ94 -

Non-Dissemination Days

Following the index methodology as described in the MVIS Global Equity Index Guide, the Index will not be disseminated on the following days:

  • 01 Jan 2021
Up